Spectrum Pharmaceuticals Cash from Operations Quarterly:
8.097M for Dec. 31, 2012Spectrum Pharmaceuticals Historical Cash from Operations Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 8.097M |
| Sept. 30, 2012 | 18.91M |
| June 30, 2012 | 18.04M |
| March 31, 2012 | 26.91M |
| Dec. 31, 2011 | 10.96M |
| Sept. 30, 2011 | 20.03M |
| June 30, 2011 | 28.64M |
| March 31, 2011 | -16.35M |
| Dec. 31, 2010 | 10.28M |
| Sept. 30, 2010 | -3.42M |
| June 30, 2010 | -3.389M |
| March 31, 2010 | -26.01M |
| Dec. 31, 2009 | -10.54M |
| Sept. 30, 2009 | -11.38M |
| June 30, 2009 | 3.974M |
| March 31, 2009 | 0.315M |
| Dec. 31, 2008 | -5.256M |
| Sept. 30, 2008 | -7.085M |
| June 30, 2008 | 11.45M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Cash From Operations
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from operations. Includes the company's cash inflows and outflows from the company's core business operations.
Cash from Operations can be thought of as "how much did the firm generate in the day to day operations of the firm?"
Learn More
SPPI Cash from Operations Quarterly Benchmarks
| Companies | |
|---|---|
| Elan | -27.60M |
| Agenus | |
| Biocryst Pharmaceuticals |
SPPI Cash from Operations Quarterly Rankings
| Overall |
75th percentile 1978 of 8002 |
| Sector |
78th percentile 144 of 684 in Healthcare |
| Industry |
89th percentile 27 of 248 in Biotechnology |
SPPI Cash from Operations Quarterly Range, Past 5 Years
| Minimum | -26.01M | Mar 2010 |
| Maximum | 28.64M | Jun 2011 |
| Average | 3.904M |
